Vos
LATEST ISSUE

May/June 2026

Prescription drug prices and national priorities vary widely across the globe, leaving patients with uneven access to potentially life-changing treatments. How can health economics and outcomes research help healthcare stakeholders negotiate lower costs for countries and households without compromising pharmaceutical innovation?
VOS-IssueCover-septOct2020
Vol. 6 No. 5

September/October 2020

Unlocking the Promise of Real-World Evidence
VOS-AP-COVER
VOL. 6, NO. 5 S1

September 2020 Supplement

September 2020 Supplement: Spotlight on Asia Pacific
VOS-Cover-082020
VOL. 6 NO. 4

July/August 2020

Behavioral Economics: Examining Human Reactions To COVID-19
VOS-May-June-2020
VOL. 6 , NO. 3

May/June 2020

Shared Risks, Shared Benefits: Innovative Pricing in Healthcare
March April 2020 VOS Cover Thumbnail
VOL. 6 NO. 2

March/April 2020

COVID-19: A Global Crisis
Value and Outcomes Spotlight - The new digital healthcare ecosystem: Looking outside the harness from within
VOL. 6 NO. 1

January/February 2020

The Digital Healthcare Ecosystem: Looking Outside to Harness From Within
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×